Number Scanned. The most common response was 1 to 5 patients scanned per week each survey year, although the percentage of sites in this category decreased steadily from 87% (13 of 15) in 2013 to 74% (14 of 19) in 2014 and 53% (9 of 17) in 2015. Only 1 site reported scanning more than 20 patients per week in each survey year.
Nodule Management Guidelines. From 2013 to 2015, there was an evolution from using a variety of nodule management guidelines toward using ACR Lung Imaging Reporting and Data System (Lung-RADS) at most sites (13 of 17 [75%]) in 2015. Concurrently, there was greater uniformity among sites regarding the size threshold of a solid nodule for a positive screening result, with most (12 of 17 [70%]) using a criterion of 6 mm in 2015.
Discussion | Our survey demonstrates several trends in LCS from 2013 to 2015, including broad adoption of ACR Lung-RADS, with associated greater conformity regarding threshold nodule size criteria for a positive screen. These findings suggest that radiology-specific guidelines have contributed to greater uniformity in LCS practices.
Despite favorable public policy decisions in support of LCS between 2013 and 2015, we observed only a modest increase in patient volume. We emphasize, however, that the timing of the survey occurred too early to determine the impact of CMS coverage on patient volumes.
By design, we targeted a focused population of leading AMCs to determine whether there is a consensus of "best practices." We acknowledge that our results may not be represen- 
Communication of Recurrence Risk Estimates to Patients Diagnosed With Breast Cancer
For patients with breast cancer to play active roles in treatment decisions, they must understand their risk of cancer recurrence and how that risk changes with different treatments. Such information is available to treating clinicians through tools such as AdjuvantOnline, We presented a clinical vignette of a 45-year-old woman with estrogen receptor (ER) and prohesterone receptor (PR) positive, ERBB2-negative (referred to as HER2 or HER2/neunegative in the vignette) breast cancer who chose to undergo lumpectomy for a pT1c, N0, grade 2 infiltrating ductal carcinoma with negative surgical margins. Participating surgeons then answered 4 questions about communication of risk information: "In a case like this, would you…" (A) "use an online calculator (like AdjuvantOnline) to help estimate the patient's recurrence risks," (B) "discuss recurrence risk using specific numerical risk estimates (eg, 10-year risk of recurrence) with the patient," (C) "discuss recurrence risk using descriptive words such as "high risk" or "low chance" (regardless of whether you provide numerical estimates to patients)," and (D) "give patients a copy of recurrence risk numbers to take home"? Response options were "definitely yes," "probably yes," "probably no," and "definitely no" and were dichotomized for analysis. Participating medical oncologists answered identi- 
